for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

TOWA PHARMACEUTICAL CO., LTD

4553.T

Latest Trade

2,743.00JPY

Change

-47.00(-1.68%)

Volume

168,900

Today's Range

2,723.00

 - 

2,795.00

52 Week Range

2,302.00

 - 

3,150.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
2,790.00
Open
2,795.00
Volume
168,900
3M AVG Volume
2.85
Today's High
2,795.00
Today's Low
2,723.00
52 Week High
3,150.00
52 Week Low
2,302.00
Shares Out (MIL)
49.21
Market Cap (MIL)
143,729.60
Forward P/E
11.99
Dividend (Yield %)
1.51

Next Event

Q3 2020 Towa Pharmaceutical Co Ltd Earnings Release

Latest Developments

More

TOWA PHARMACEUTICAL says patent infringement suit

TOWA PHARMACEUTICAL announces shareholding change

TOWA PHARMACEUTICAL announces equipment investment of Yamagata factory

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About TOWA PHARMACEUTICAL CO., LTD

TOWA PHARMACEUTICAL CO., LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. Its main products are generic drugs, which include nervous system drugs, allergy drugs, cardiovascular drugs, hormone drugs, vitamin drugs, metabolic drugs, antibiotic drugs and chemotherapy drugs, among others.

Industry

Major Drugs

Contact Info

2-11, Shimbashi-cho

+81.6.69009100

https://www.towayakuhin.co.jp/

Executive Leadership

Itsuro Yoshida

President, Chairman of Subsidiaries, Representative Director

Kazuhiko Konno

Managing Director, Chairman of Subsidiary

Norikazu Inoue

Senior Executive Officer, Chief Director of Administration, Director of General Affairs

Sadayuki Morino

Senior Executive Officer, Chief Director of Purchasing

Yasushi Naito

Senior Executive Officer, Chief Director of Sales

Key Stats

2.50 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2017

0.1K

2018

0.1K

2019

0.1K

2020(E)

0.1K
EPS (JPY)

2017

113.320

2018

131.997

2019

273.850

2020(E)

232.673
Price To Earnings (TTM)
10.33
Price To Sales (TTM)
1.29
Price To Book (MRQ)
1.40
Price To Cash Flow (TTM)
6.34
Total Debt To Equity (MRQ)
64.04
LT Debt To Equity (MRQ)
56.37
Return on Investment (TTM)
9.63
Return on Equity (TTM)
7.80

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up